SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
Xiaomi Automobile: February delivery volume exceeds 20,000 vehicles
New Stock News | Continuous Decline in Profit, Shanghai Pigeon Submits Disclosure Form to Hong Kong Stock Exchange for the Third Time
New stock news | Shanghai Pigeon submits documents to Hong Kong Stock Exchange for the third time
Xiaomi Automobile: February delivery volume exceeds 20,000 vehicles
New Stock News | Continuous Decline in Profit, Shanghai Pigeon Submits Disclosure Form to Hong Kong Stock Exchange for the Third Time
New stock news | Shanghai Pigeon submits documents to Hong Kong Stock Exchange for the third time
RECOMMEND
Robot Concept Hong Kong Stocks Retreat After Spring Gala Rally As 2026 Emerges As Pivotal Year For Mass Production And Commercialization
25/02/2026
Hong Kong IPO Fundraising Surges Tenfold At Start Of Year As 110 A‑Share Companies Queue For Listings
25/02/2026
AI Iteration Risks Surface As Hong Kong Market Diverges; Low‑Valuation, High‑Dividend Legacy Stocks Attract Capital As Safe Havens
25/02/2026
